by The global Shigella Test Kit Market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Shigella test kits are used to detect Shigella bacteria which causes shigellosis. Shigellosis is a contagious bacterial infection that is transmitted through contaminated food and water. Shigella test kits provide accurate results within a short period of time thereby allowing physicians to prescribe appropriate treatment and manage transmission.
Market key trends:
Shigella infections are more common in developing regions with poor sanitation and hygiene conditions. According to WHO, globally 164.7 million cases of shigellosis occur annually, majority of which are among children in developing countries. The rising burden of shigellosis infections globally is expected to drive the demand for shigella test kits over the forecast period. Additionally, development of rapid point-of-care diagnostic tests for shigellosis with improved accuracy and shorted detection time will further support the market growth. Growing awareness regarding waterborne diseases and availability of reimbursements for diagnostic tests in developed regions will also contribute to the market expansion.
Market key trends:
The Shigella test kit market is witnessing increasing demand for rapid and accurate diagnosis of shigellosis. Rapid diagnostics tests that can provide results within hours are gaining more preference over conventional cultures due to the need for timely initiation of antibiotics and to prevent the spread of infection. Lateral flow assays and PCR-based molecular diagnostic tests have emerged as popular rapid diagnostic methods for Shigella as they can significantly reduce the time required for results compared to cultures.
SWOT Analysis
Strength: Rapid diagnostic tests have reduced diagnosis time compared to conventional cultures.
Weakness: High cost of molecular diagnostic tests limits their use in resource-poor settings.
Opportunity: Rising prevalence of shigellosis globally increases the need for improved diagnostics.
Threats: Limitations of current rapid tests in terms of sensitivity impact their acceptance. Stringent regulatory framework further increases compliance costs.
Key Takeaways
The global Shigella test kit market is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing incidence of shigellosis globally. North America is expected to dominate the market during the forecast period owing to developed healthcare infrastructure and increasing adoption of rapid diagnostic tests in the region.
The global Shigella test kit market size for 2023 is US$ 106.4 Mn. Asia Pacific region is witnessing fastest growth and expected to grow at highest CAGR during forecast period due to large population base and improving healthcare facilities in emerging economies such as India and China.
Key players operating in the Shigella test kit market are Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., CTK Biotech Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
